Assessing Therapeutic Efficacy in Real-time by Hyperpolarized Magnetic Resonance Metabolic Imaging

Area of Science:

• Oncology
• Medical Imaging
• Biochemistry

Background:

• Clinical measurement of tumor metabolism aids therapeutic response assessment.
• Positron Emission Tomography (PET) with [18F]FDG is a standard clinical metabolic imaging tool.
• Hyperpolarized Magnetic Resonance (HP-MR) enhances MRI sensitivity for functional and metabolic imaging.

Purpose of the Study:

• To review the clinical applications of metabolic imaging using hyperpolarized MRI.
• To explore the potential of HP-MR in assessing therapeutic interventions across various cancer types.

Main Methods:

• Review of current literature on hyperpolarized MRI in oncology.
• Focus on clinical translation of 13C-pyruvate metabolism measurements.
• Discussion of HP-MR's role in evaluating cancer treatment efficacy.

Main Results:

• Hyperpolarized MRI provides highly sensitive metabolic information.
• Clinical translation of HP-MR for 13C-pyruvate imaging has been achieved.
• Metabolic imaging with HP-MR shows promise for monitoring cancer therapy.

Conclusions:

• Hyperpolarized MRI is a promising tool for clinical metabolic assessment in oncology.
• This technique can offer valuable insights into therapeutic efficacy by visualizing metabolic changes.
• Further clinical studies are warranted to fully establish HP-MR's role in cancer management.